Twitter | Pretraživanje | |
Innovation Endeavors
portfolio company partners with  to use condensate biology to find new treatments for cardiovascular and gynecological diseases. More via
Dewpoint Therapeutics, the biotech working to drug biomolecular condensates, has struck its first big deal. It’s teaming up with Bayer on new treatments for a pair of neglected fields: heart disease...
Reply Retweet Označi sa "sviđa mi se" More